OC and EVOO phenolics targeted critically important molecular targets, including the lysine methyltransferases SMYD2 and EZH2, which activate several downstream protein substrates important for CRC growth, progression and motility. This evidence concerns the gene SMYD2 and colorectal carcinoma.